Publication | Closed Access

Randomized Phase III Trial Results of Panitumumab, a Fully Human Anti—Epidermal Growth Factor Receptor Monoclonal Antibody, in Metastatic Colorectal Cancer

Gastrointestinal OncologyMedicineImmunologyColorectal CancerPathologyMetastatic Colorectal CancerImmunotherapyOncologyRadiation Oncology